Bioinformatics Market Size To Expand at a Notable CAGR Of 14.50% During 2023-2030.

"August 2022, Market Research Future has published a Report on the Global Bioinformatics Market."

Global Bioinformatics Market – Overview

The Bioinformatics Market is expected to reach USD 26.8 billion by 2030 at 14.50% CAGR during the forecast period 2023-2030

The volume of biological research that is being conducted globally is hugely benefitted from the use of bioinformatics. Market reports connected with healthcare industry have been offered by Market Research Future which creates reports on other industry verticals that intends to analyze the current market scenarios better. 

The development of the information technology sector has substantially benefitted the growth pace of the bioinformatics market. The ease related to the generation of large data sets provided by bioinformatics has sped up the research pace in various fields and has consequently improved the demand for the market for bioinformatics. The bioinformatics is estimated to have ample scope for progress in the upcoming period due to the need to address longstanding complex biological questions that can possibly alter the overall quality of human life.

Segmental Analysis

The segmental analysis of the bioinformatics market has been carried out on the basis of application, services & technology, sector, and region. On the basis of application, the bioinformatics market is segmented into chemoinformatics, genomics, drug design, transcriptomics, proteomics, metabolomics, molecular phylogenetics, DNA sequences, and others. Based on services and technology, the bioinformatics market is segmented into sequence analysis, data warehousing, sequence manipulation, and others. Based on sector, the bioinformatics market is segmented into animal bioinformatics, medical bioinformatics, agriculture bioinformatics, and others. The regions considered in the bioinformatics market are the Americas, Europe, Asia Pacific, Middle East, and Africa.

Detailed

Regional Analysis

The regional analysis of the bioinformatics market consists of regions such as Americas, Europe, Asia Pacific, Middle East, and Africa. The Americas region is the major market for bioinformatics. The presence of countries such as the US and Canada have a significant role in the development of the bioinformatics market. The European region is estimated to lead the next biggest market which is anticipated to achieve significant growth by the end of the forecast period. Furthermore, the Asia Pacific region is anticipated to be the most rapidly growing region in the bioinformatics market.

Competitive Analysis

The fresh implementation of strategies is expected to motivate the market in the impending years. The development of a strong value chain is encouraging the expansion of the market. The vertical additions and product tactics of the market are enhancing the potential of the market companies. Substantial cutbacks in administrative budgets are bringing further development of the market. The augmented conformity of market players to new clients and market trend predispositions are advancing the growth curve of the market and will continue in the forecast period. The planned goals envisioned for the market are buoyed due to beneficial product differentiation supported by market contestants. The development of the market is moving in a favorable direction due to original product introductions or escalating gross revenue of the players in the market. The significant contenders in the bioinformatics market globally are Illumina, Inc., QIAGEN N. V, Agilent Technologies, Thermo Fisher Scientific Inc., Dassault Systèmes and others.  

Industry Updates:

Dec 2018 Crown Bioscience has extended its translational oncology research facility by launching a new site in Suzhou, China.

The huge amount of data now obtainable from preclinical and clinical research entails dedicated expertise in bioinformatics, big data analysis, and reserved storage facilities. CrownBio’s novel site will emphasize on mixing the company’s experience in translational and preclinical research with pioneering digital technologies for the detection of predictive biomarkers and the expansion of new and companion diagnostics.

Oct 2018 Researchers at Stanford (Calif.) University have discovered that hospital-acquired bloodstream infections are usually triggered by a patient's digestive tract. For the execution of the study, researchers have deployed a bioinformatics software to examine blood and stool samples from 30 patients who acquired a bloodstream infection after getting a bone-marrow transplant.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Bioinformatics Market Research Report